Table 1.
Drug | Pharmacokinetic | Pharmacodynamic |
---|---|---|
Thiopentone (85%reduction), Etomidate | Decreased initial volume of distribution (Vd). decreased clearance (half-life 13-25 h versus 6-12 h in young) | |
Propofol, midazolam | Decreased clearance | Increased brain sensitivity |
Morphine (morphine-6 glucuronide) | Decreased clearance | Reduced renal clearance Increased brain sensitivity |
Fentanyl, sufentanil, alfentanil | Increased brain sensitivity | |
Remifentanil | Reduced central compartment volume | Increased brain sensitivity |
Neuromuscular blockers | Prolonged action of drug undergoing hepatic metabolism Dose unchanged | |
Neostigmine | Dose unchanged | More cardiac adverse effects |